Your browser doesn't support javascript.
loading
Real-world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR-2 retrospective chart review study.
Hess, Georg; Dreyling, Martin; Oberic, Lucie; Gine, Eva; Zinzani, Pier Luigi; Linton, Kim; Vilmar, Adam; Jerkeman, Mats; Chen, Jenny M H; Ohler, Anke; Stilgenbauer, Stephan; Thieblemont, Catherine; Lambert, Jonathan; Zilioli, Vittorio Ruggero; Sancho, Juan-Manuel; Jiménez-Ubieto, Ana; Fischer, Luca; Eyre, Toby A; Keeping, Sam; Park, Julie E; Wu, James J; Siddiqi, Rubina; Reitan, John; Wade, Sally; Salles, Gilles.
Affiliation
  • Hess G; Department of Hematology, Oncology and Pneumology, Comprehensive Cancer Center, University Medical School of the Johannes Gutenberg-University, Mainz, Germany.
  • Dreyling M; Medizinische Klinik III, LMU Klinikum, Munich, Germany.
  • Oberic L; Service d'Hématologie, Toulouse, France.
  • Gine E; Department of Hematology, GELTAMO, Hospital Clínic of Barcelona, Barcelona, Spain.
  • Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia 'Seràgnoli', Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.
  • Linton K; The Manchester Cancer Research Center, Manchester, UK.
  • Vilmar A; Odense University Hospital, Odense, Denmark.
  • Jerkeman M; Department of Oncology, Skane University Hospital and Lund University, Lund, Sweden.
  • Chen JMH; PRECISIONheor, Vancouver, Canada.
  • Ohler A; Department of Hematology, Oncology and Pneumology, Comprehensive Cancer Center, University Medical School of the Johannes Gutenberg-University, Mainz, Germany.
  • Stilgenbauer S; Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Thieblemont C; APHP, Hôpital Saint-Louis, Hemato-Oncologie, Université de Paris, Paris, France.
  • Lambert J; University College London Hospitals NHS Foundation Trust, London, UK.
  • Zilioli VR; Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Sancho JM; GELTAMO, Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Badalona, Spain.
  • Jiménez-Ubieto A; GELTAMO, Hospital Doce de Octubre, Madrid, Spain.
  • Fischer L; Medizinische Klinik III, LMU Klinikum, Munich, Germany.
  • Eyre TA; Oxford University Hospitals, Oxford, UK.
  • Keeping S; PRECISIONheor, Vancouver, Canada.
  • Park JE; PRECISIONheor, Vancouver, Canada.
  • Wu JJ; Kite Pharma, Santa Monica, California, USA.
  • Siddiqi R; Kite Pharma, Santa Monica, California, USA.
  • Reitan J; RJM Group, LLC, Crown Point, Indiana, USA.
  • Wade S; Wade Outcomes Research and Consulting, Salt Lake City, Utah, USA.
  • Salles G; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Br J Haematol ; 202(4): 749-759, 2023 08.
Article in En | MEDLINE | ID: mdl-36257914
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Mantle-Cell Type of study: Risk_factors_studies Limits: Adult / Humans Country/Region as subject: Europa Language: En Journal: Br J Haematol Year: 2023 Document type: Article Affiliation country: Germany Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Mantle-Cell Type of study: Risk_factors_studies Limits: Adult / Humans Country/Region as subject: Europa Language: En Journal: Br J Haematol Year: 2023 Document type: Article Affiliation country: Germany Country of publication: United kingdom